dc.contributor.author
Lüftner, Diana
dc.contributor.author
Fasching, Peter A.
dc.contributor.author
Haidinger, Renate
dc.contributor.author
Harbeck, Nadia
dc.contributor.author
Jackisch, Christian
dc.contributor.author
Müller, Volkmar
dc.contributor.author
Schumacher-Wulf, Eva
dc.contributor.author
Thomssen, Christoph
dc.contributor.author
Untch, Michael
dc.contributor.author
Würstlein, Rachel
dc.date.accessioned
2023-06-14T12:28:32Z
dc.date.available
2023-06-14T12:28:32Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/39824
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-39545
dc.description.abstract
Background: The first International Consensus Conference for Advanced Breast Cancer (ABC1) took place 10 years ago in November 2011. The rationale was - and still is - to standardize treatment of advanced breast cancer (ABC) based on the available evidence and to ensure that worldwide all breast cancer patients receive adequate treatment and access to new therapies. Rationale for the Manuscript: The 6th International Consensus Conference for ABC (ABC6) took place from November 4 to 6, 2021 and was the first in a purely online format, due to the COVID-19 pandemic. In the present manuscript, a working group of German breast cancer experts comments on the voting results of the ABC6 panelists regarding their applicability for routine clinical practice in Germany. Method: The ABC6 votes mainly include modified or new statements. With regard to all statements not modified for the ABC6 consensus, the German experts refer to the published paper of the ABC5 consensus. The German experts base their comments on the current recommendations of the Breast Committee of the Gynecological Oncology Working Group (Arbeitsgemeinschaft Gynakologische Onkologie, AGO Mamma). Topics: ABC6 focused on new treatment options and their implications for clinical practice. Optimal therapy sequencing for example was one of the issues. To solve the challenge of a more individualized treatment, precision medicine is fundamental. Oligometastatic disease, brain metastases and adequate supportive and palliative care were also addressed. Of special interest was the treatment of inoperable locally advanced breast cancer, which was discussed as a separate topic. As in previous years, patient advocates from around the world were an integral part of the ABC6 conference and had a major input into the consensus.
en
dc.subject
Advanced breast cancer
en
dc.subject
Systemic therapy
en
dc.subject
Therapeutic sequence
en
dc.subject
Oligometastasis disease
en
dc.subject
Brain metastases
en
dc.subject
Supportive care
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
ABC6 Consensus: Assessment by a Group of German Experts
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1159/000522068
dcterms.bibliographicCitation.journaltitle
Breast Care
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Karger
dcterms.bibliographicCitation.pagestart
90
dcterms.bibliographicCitation.pageend
100
dcterms.bibliographicCitation.volume
17
dcterms.rightsHolder.note
Copyright applies in this work.
dcterms.rightsHolder.url
http://rightsstatements.org/vocab/InC/1.0/
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.note.author
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
de
refubium.note.author
This publication is shared with permission of the rights owner and made freely accessible through a DFG (German Research Foundation) funded license at either an alliance or national level.
en
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35355695
dcterms.isPartOf.issn
1661-3791
dcterms.isPartOf.eissn
1661-3805